BRCA2 and ovarian cancer: Approximately 5–10% of all BCs have family history of breast or ovarian cancer, and women with germline mutations in breast cancer type 1 (BRCA1) and type 2 (BRCA2) are of greater risk of developing breast or ovarian cancer [72].